The 5-Minute Investor Podcast, Ep. 85: Standout AI healthcare stocks

Listen to episode 85 of The 5-Minute Investor Podcast, featuring analysis on AI healthcare stocks Diagnos and CeriBell.

Small-cap Canadian healthcare firm expands AI-screening at home and abroad

Diagnos (TSXV:ADK) uses AI through its CARA platform to help detect eye diseases like diabetic retinopathy & age-related macular degeneration

This healthtech company improves neurological care with AI

CeriBell is a healthtech company applying AI to neurological critical care, vastly improving diagnoses versus legacy technology.

AI stock gains on Medicaid coverage breakthrough

DataMeds AI (NASDAQ:MEDS) gained investor attention after Helomics secured Humana Medicaid coverage for the ChemoFx cancer assay.
Illustration of a home as a piggy bank

How did Invesque get to be the top gainer on the TSX?

Invesque (TSX:IVQ) agreed to a go-private transaction with a Magnetar-managed entity at US$0.101 per share (about C$0.143 per share).

Buzz on the Bullboards: 3 TSX stocks making headlines as markets navigate a volatile week

While the TSX has struggled to gain momentum this week, three stocks to watch as Whitecap, BlackBerry, and WELL Health make headlines.

Cancer fighter Theralase aims to turn lab wins into human trials

Theralase (TSXV:TLT) begins Good Laboratory Practice toxicology analysis of Rutherrin, its drug candidate to target and destroy cancer cells.

Restart Life Sciences serves up exponential revenue growth

Restart Life Sciences (CSE:HEAL) more than doubled revenue at stable profit margins in Q2 2026 amid several promising commercial activations.
The Market Online Video

NurExone Biologic progresses towards a new regenerative therapy and sets sights on a potential NASDAQ listing

NurExone CEO Dr. Lior Shaltiel discusses U.S. exosome manufacturing, Mexico expansion, ExoPTEN and plans for a potential U.S. listing.
The Market Online Video

Med-X targets global pest control market with Nature-Cide

Med-X CEO Matthew Mills discusses Nature-Cide, professional pest control partnerships, global expansion and the company’s planned Nasdaq listing.

The 5-Minute Investor Podcast, Ep. 76: Breaking down Curaleaf’s bid for Aurora Cannabis

Listen to episode 76 of The 5-Minute Investor Podcast, featuring analysis on cannabis stocks Curaleaf and Aurora.
The Market Online Video

AI-powered automation for the beauty and wellness industry

Yocale.ai CEO Aydin Asli discusses its AI platform, beauty and wellness strategy, C$1.74 million financing and acquisition plans.

Glow Lifetech keeps growth train rolling

Biotech and cannabis innovator Glow Lifetech (CSE:GLOW) posted its 12th consecutive quarter of year-over-year revenue growth in Q2 2026.

3 ambitious pharma stocks near commercialization

A concise look at Abivax, Q32 Bio and Achieve Life Sciences, three pharma stocks keen to solve some of healthcare's most vital unmet needs.